We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.
A start-up says its model wrote new viruses to kill an infection antibiotics could not touch, and doctors gave them to a patient. It calls that compassionate use, which the FDA puts outside trials…
A start-up says its model wrote new viruses to kill an infection antibiotics could not touch, and doctors gave them to a patient. It calls that compassionate use, which the FDA puts outside trials…